NDC 62135-948 – Repaglinide
Repaglinide 2 mg/1 · Tablet · Oral
Product NDC62135-948
Product details
- Brand name
- Repaglinide
- Generic name
- Repaglinide
- Labeler
- Chartwell RX, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA078555
- Marketed since
- January 22, 2014
- Listing expires
- December 31, 2026
- Pharmacologic class
- Glinide
Active ingredients
- Repaglinide 2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62135-948-90 | 90 TABLET in 1 BOTTLE (62135-948-90) | Apr 24, 2025 |
Other Repaglinide products
- 60687-560 Repaglinide 1 mg/1 · Tablet · American Health Packaging
- 65862-672 Repaglinide 2 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-671 Repaglinide 1 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-670 Repaglinide .5 mg/1 · Tablet · Aurobindo Pharma Limited
- 72162-2558 Repaglinide 1 mg/1 · Tablet · Bryant Ranch Prepack
- 71335-2598 Repaglinide 2 mg/1 · Tablet · Bryant Ranch Prepack
- 71335-2554 Repaglinide .5 mg/1 · Tablet · Bryant Ranch Prepack
- 63629-4866 Repaglinide .5 mg/1 · Tablet · Bryant Ranch Prepack
- 62135-946 Repaglinide .5 mg/1 · Tablet · Chartwell RX, LLC
- 62135-947 Repaglinide 1 mg/1 · Tablet · Chartwell RX, LLC
- 33342-249 Repaglinide 1 mg/1 · Tablet · Macleods Pharmaceuticals Limited
- 33342-250 Repaglinide 2 mg/1 · Tablet · Macleods Pharmaceuticals Limited